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Abstract 
The purposes of this study are to study the pathogenesis of 
oral cancer and to see the role play of oncogenes, onco-suppressor 
genes in cancer growth and their mutation type. There are many 
predisposing factors which may influence the development of 
cancer. The factors are divided intrinsic (hereditary) and extrinsic 
factors (bacteria, viruses, fungi, chemical, drugs, radiation, trauma, 
heat, cold and nutrition). These agents may act individually, in 
combination with other carcinogen (co-carcinogen) or in 
combination with other agents that do not in themselves causes 
cancer (promoters), but that help the carcinogens to mutate or 
depress cells, but in the mechanism still enigma. Oncogenes onco-
suppressor genes are normal genes in human. Oncogenes 
functions are as growth factor (e.g. sis), growth factor receptor 
(e.g. erbB1), signal transducer (e.g. ras) or nuclear factor (e.g. 
myc, jun). Tumor (oral cancer) will be arises if oncogenes and 
onco-suppressor genes function are disturbed by some carcinogen 
and these genes have mutation, deletion, amplification or 
translocation. That was also related to the loss or inactivation of 
onco-suppressor genes such as p53, so that causes the loss of the 
normal growth regulation/strait control that associated with 
tumorigenesis. 
 
 
Introduction 
Cancer of oral cavity is one of the 
numbers cancer in the body and Oral Squamous 
Cell Carcinoma (OSCC) accounts for more than 
95% of all cancer in the oral cavity (Saku T, 
2008) and most of oral cancers arise in the 
tongue which majority of oral cancer present at 
an advanced stage III or IV. Epidemiological 
study and experimental evidence indicate a 
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causal relationship between some carcinogenic 
with oral cancer such as chewing tobacco, betel 
quid chewing, smoking and drinking. (1-4), but 
the exact cause of cancer is unknown. 
There are many predisposing factors, 
which may influence the development of cancer. 
These factors are divided into intrinsic 
(hereditary,developmental factors) and extrinsic 
factors (bacteria, viruses, fungi, chemical, drugs, 
radiation, trauma, heat, cold and nutrition).(5,6) 
These  agents  may act  individual ly ,  in 
combination with other carcinogen (co-carcino 
gen) or in combination with other agents that do 
not in themselves cause cancer (promoters), but 
that help the carcinogens to mutate or depress 
cells.(6) 
According to Reksoprawiro (2008) report 
the incidence of oral cancer in DR. Soetomo 
hospital Surabaya, Indonesia from 1998-2007 
was 184 cases, which sex ratio between male 
and female was 50% to 50% and the high 
frequency in age distribution was female was 41 
to 50 year old and male was 51 to 60 year old 
(Fig. 1). 
 
 
 
 
 
 
 
 
 
 
Figure 1: Sex and age distributions of oral cancer patients at DR. Soetomo  Hospital, Surabaya, Indonesia in 
year 1997-2007. (Source: Reksoprawiro S. Surgery in locally advanced oral cancer. 2008) 
 
It is amazing that not all of carcinogens 
cause cancer, when we consider the numerous 
carcinogens encountered daily. There might be 
certain internal mechanisms that either afford 
protection to humans or make the susceptible. 
One of these internal mechanisms may be 
genetic susceptibility or resistance.(7,8) However, 
the molecular basis of oral cancer is still enigma.  
Oncogenes are genes present in human 
cells, but were originally identified in 
retroviruses, hence the nomenclature v-onc. 
They have mutated to produce abnormal 
products. Onco-suppressor (tumor suppressor) 
genes are normal genes that its function as 
depressor of cancer development. 
Carcinogenesis is a sequence of cancer 
formation process. The purpose of this study of 
pathogenesis of oral cancer and to see the role 
play of oncogenes in cancer growth.  
 
 
Literature Review Pathogenesis Of Oral 
Cancer 
It has been know for a long time that 
cancer has a multifactorial etiology and is a 
multi step process involving initiation, 
promotion and tumor progression (9,10). 
Oncogenes have been implied to play a critical 
role in various stages of human tumors. The 
proto-oncogenes in normal cells may be 
activated and contribute to neoplastic 
transformation through point mutations, 
translocation, deletions, amplification or other 
genetic mechanism.(11) The common mechanism 
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for cancer initiation appears to be through 
damage to DNA resulting in uncontrolled cell 
proliferation. 
There are several gene classes involved in 
carcinogenesis, which is effected by genetic 
changes. They are Oncogenes, Tumor 
suppressor genes, metastasis genes and DNA 
repair genes.(12) 
 
 
 
 
Oncogenes 
Oncogenes are important cellular genes 
which, in general, act in a positive way in the 
normal growth regulatory pathway of the cell. 
Oncogenes can act as growth factors, growth 
factor receptors, signal transducers and nuclear 
factor (Figure 2 & 3). Oncogenes are very 
closely related to proto-oncogenes, but they 
have mutated to produce abnormal 
products, or control mechanism have altered to 
allow gene-expression and thus they have lost 
the normal activity.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Involvement of Oncogenes in normal growth signal pathway 
(Source: Quirke P and Cawkwell L. Molecular Genetics of Cancers) 
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Figure 3:   Roles of various proto-oncogenes at several of transmission of growth signal (Source: Scully C.    
      Oncogenes, onco-suppressor, carcinogenesis and oral cancer. 1992) 
Several oncogenes and their association with various malignancies are shown in Table 1. 
      Table 1. Oncogenes association with various malignant neoplasms 
Oncogene Associated neoplasm Mechanism of activation 
Abl Chronic myelogenous 
Leukemia 
Translocation 
ErbB1 Squamous carcinoma 
Glioblastoma 
Amplification 
   
ErbB2 Adenocarcinoma of breast and ovary Amplification 
Myc Burkitts lymphoma  
Small cell carcinoma of lung  
Carcinoma breast and cervix 
Translocation  
 
Amplification 
L-myc Small cell carcinoma of lung Amplification 
N-myc Neuroblastoma Amplification 
 Retinoblastoma  
 Small cell carcinoma of lung  
K-ras Carcinoma of colon, lung and pancreas Amplification and Point 
mutation 
N-ras Acute myelogenous and Lymphoblastic 
leukemia some carcinomas 
Point mutation 
H-ras Carcinomas of genitourinary tract and thyroid Point mutation 
Bcl-1 B cell lymphoma Translocation 
Bcl- 2 Follicular lymphoma Translocation 
P53 Head and Neck Cancer Amplification and Point 
mutation, deletion 
       (Sources: Scully C. Oncogenes, onco-suppressor, carcinogenesis and oral cancer. 1992) 
 
Oncogenes may be associated with 
carcinogenesis, but this is not sufficient for 
tumor formation. Some carcinogenic agents 
such as viruses can affect proto-oncogenes by 
stealing genes, by inducing translocations, or by 
inserting their oncogenes into host DNA. Other 
viruses can affect tumor suppressor genes such 
as p53 gene (13). Chemical carcinogens or 
ionizing radiation can also produce similar 
effects on proto-oncogenes (10,13). Proto-
oncogenes can be activated by a number of 
oncogenic agents acting in one of 4 main ways 
(10): 
 
1. Point mutations. For example, mutations are 
found in some colon, breast, and oral cancer 
(Fig. 4). 
2. Transduction and insert ional mutagenesis. 
For example, some retroviruses can cause 
DNA damage, or can integrate next to a 
proto-oncogenes and active transcription. 
3. Chromosomal rearrangements and 
chromosome translocation. For example, 
many hematological malignancies such as  
Burkitt’s lymphoma result from 
translocation. 
4. Amplification, producing many extra copies 
of the proto-oncogene. For example c-myc 
and erbB are amplified in some breast and 
oral carcinomas and then often 
accompanied by karyotypic abnormalities, 
poor prognosis, and resistance to cytotoxic 
drugs. 
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Figure 4. Point mutations of p53 gene found in oral cancer (oral Squamous Cell 
Carcinoma) which CGA (arginine) to TGA  (stop codon). (Source: Syafriadi and Saku. 2007) 
 
Saranath et. al., (1989), found that there 
was amplification of several oncogenes, 
including c-myc, N-myc, Ki-ras, in squamous 
cell carcinoma of oral cavity. They had 
suggested that these oncogenes may be 
alternatively or simultaneously activated in oral 
carcinogenesis. 
Amplified oncogene N-myc has been 
identified also in 89 cases of neuroblastomas, 
the frequency and degree of amplification in 
primary neuroblastomas varied greatly about 
three and 300 copies in 34 out 89 tumors. (14) 
 
Tumor Suppressor Genes 
Tumor suppressor gene products are 
involved in the negative control of cell 
proliferation and differentiation for example is 
p53. The loss or inactivation of these genes is 
associated with tumorigenesis by the loss of the 
normal growth regulation/restrain control or 
apoptosis. Inactive of tumor suppressor genes 
caused by mutation and loss of heterozygosity 
or DNA metylation. There are many tumor 
suppressor genes as follow: p53 at chromosome 
17p, ‘mutated in colorectal cancer’ (MCC) gene 
at 5q, ‘dilated in colorectal cancer’ (DCC) gene 
located on 18q21, prohibition gene at 17q21, 
krev-1/rap 1A located at 1p13-p12, Gas-1 
(growth arrest specific) genes have been 
identified that are expressed especially in cells 
in resting stage (Go). (9) 
 
 
 
 
Metastasis Genes 
Malignant cells, which leave the primary 
tumor and colonies distant sites, are the major 
cause of death in patients with solid tumor. The 
complexity of the metastases process suggests 
that it may be under genetic control. Genes 
involved in metastasis are nm23-H1 (NME1) 
and nm23-H2 (NME2). A combined loss of 
chromosomes 11p and 17 p was associated with 
a significantly higher incidence of metastasis in 
regional lymph  nodes of breast cancer. (15) 
Angiogenesis is required for expansion 
of the primary tumor, and new blood vessels 
penetrating the tumor are frequent sites for entry 
of tumor cells into the circulatory system. Cell 
must first detach them selves from the primary 
tumor and it has been suggested that malignant 
cells have a reduced ability to adhere to each 
other. (12) 
 
Apoptosis Genes 
The production of tumors includes 
disturbances of the mechanism that control cell 
death by apoptosis since cells escape normal 
ageing and death. It is the myc gene that acts as 
a bivalent regulator of both cell proliferation 
and apoptosis depending on the availability of 
growth factors. The normal p53 protein appears 
to be involved in the induction of apoptosis in 
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susceptible cells. Activated ras, bcl-2 or p53 
oncogenes may rescue cells from susceptibility 
to apoptosis, leading to population expansion. 
(16,17) 
 
   
Figure 5. Oral Squamous Cell Carcinoma (A). Tunel staining showed no apoptotic cell 
in tumor nests of oral SCC (B). p53 gene analysis showed there was point mutation found 
 
DNA Repair Genes 
Mutation in DNA repair genes are known 
to lead some cancers. Failure of repair has been 
associated with Xeroderma pigmentosum, 
Ataxia telangiectasia, Fanconi’s anemia, 
Bloom’s syndrome, and Cockayne’s syndrome. 
(12) 
 
 
Conclusion 
Each chromosome has some oncogenes 
and onco suppressor genes. Oncogenes are 
important cellular genes which, in general, act 
in a positive way in the normal growth 
regulatory pathway of the cell. Recently, more 
than 50 oncogenes have been identified ; their 
associations with neoplasm are various. For 
example, e-myc, L-myc, N-myc, ki-ras and N-
ras. All of this oncogene was found related with 
squamous cell carcinoma of the oral cavity. 
Alteration of some carcinogenic such as 
bacteria, viruses, fungi, chemical, drugs, 
radiation, trauma, heat could in these genes may 
disrupt normal cell functions through damaging 
DNA. Some carcinogenic agents such as viruses 
can affect proto-oncogenes by point mutations, 
deletion, amplification, translocations or 
inserting near or within proto-oncogenes and 
thereby influence their activity. That was also 
related with loss or inactivation of tumor 
suppressor genes such as p53 so that causes loss 
of the normal growth regulation/restraint 
controls that associated with tumorigenesis. 
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